COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium
02/02/2018
NEW YORK and CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Epigenetics Research Conference
02/02/2018
NEWTOWN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today [...]
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT
02/02/2018
MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc , formerly Skyline Medical Inc, (NASDAQ: SKLN ) (NASDAQ: AIPT ) (“Precision Therapeutics” or the “Company”), is pleased to announce that its [...]
Sorrento Therapeutics CEO Dr Ji to Present at LEERINK Partners 7th Global Healthcare Conference on 02/15/18
02/02/2018
SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at LEERINK Partners 7th Annual Global Healthcare Conference (Lotte New York [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
02/02/2018
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018
02/02/2018
REDWOOD CITY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next generation Pantheris® [...]
Arcturus Therapeutics Appoints Mark Herbert as Interim President
02/02/2018
SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced that Mark R. Herbert, Vice President of Business Development and Alliance [...]
The American Health Council Appoints Theresa Gutierrez, MSN, RN, FNP to Nursing Board
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Theresa Gutierrez, MSN, RN, FNP, has been appointed to the American Health Council’s Nursing Board. Ms. Gutierrez brings an abundance of experience from spending 21 years [...]
PetVivo Holdings, Inc. Approaches Commercial Production
02/02/2018
MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- A long-awaited day is approaching for PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKETS:PETV), an emerging biomedical device company. We are speaking of commercial [...]
Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
02/02/2018
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe [...]
Extendicare Announces Timing of 2017 Fourth Quarter and Year End Results and Conference Call
02/02/2018
MARKHAM, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the fourth quarter and year ended [...]
Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call on February 7
02/02/2018
REHOVOT, Israel, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company focused on orphan indications, today announced that it will release financial [...]
Cory Klippsten appointed to Millennium Blockchain Board of Advisors
02/02/2018
Advisor to Top Blockchain Projects, Tech Startups and VCs, formerly of Google, McKinsey and Microsoft LAS VEGAS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC:THCT) (the “Company”) is pleased to [...]
Immunovaccine to Present at 2018 BIO CEO & Investor Conference
02/02/2018
HALIFAX, Nova Scotia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced it will participate in this year’s BIO CEO and Investor [...]
Trevena Promotes Carrie Bourdow to Executive Vice President and Chief Operating Officer
02/02/2018
CHESTERBROOK, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced the promotion of Carrie L. Bourdow from Senior Vice President and Chief Commercial Officer to Executive Vice President [...]
Recro Pharma Announces Key Sales Team Additions
02/02/2018
MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum
02/02/2018
90% of evaluable patients show clinical improvement in the ongoing Phase 1 clinical trial of MRG-106. 80% of patients treated with 300 mg IV infusion, the anticipated Phase 2 clinical trial dose, demonstrated an [...]
Aixplorer® and Aixplorer® Ultimate Ultrasound Diagnostic Systems Receive 510(k) Clearance for Clinical Management of Liver Disease
02/02/2018
AIX-EN-PROVENCE, France, Feb. 02, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that the Aixplorer® and Aixplorer® [...]
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the Third Annual ACTRIMS Forum 2018
02/02/2018
100% reduction of T1 Gd-enhancing lesions at week 24 (n=38) 99% median B-cell depletion was observed at week 4 and maintained at week 24 (n=40) TG-1101 was well tolerated across all patients including those receiving 1 [...]

Pages